VEGF-D inhibitors (Circadian Technologies)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameVEGF-D inhibitors (Circadian Technologies)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVascular endothelial growth factor D inhibitors
TargetsVascular endothelial growth factor D
Therapy Area/IndicationsLymphangioleiomyomatosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesOpthea Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOpthea Ltd
Active IndicationsN/A
Inactive IndicationsLymphangioleiomyomatosis

Other Information

ATC CodeN/A
Related LinksN/A